IN FOCUS

Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals

Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?

15 October 2024

To genotype or not to genotype, that is the question

Our genes contribute anything from 15 to 95% of how we react to medicines. Why is this the case, and when is genetic testing necessary to avoid the risk of potential side effects?

21 August 2024

Making fewer medication errors – Education and training remain key

Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?

02 April 2024

Guardians of Health: Vigilant surveillance of HIV and TB medicines in Namibia

The introduction of new medications for HIV and TB in Namibia required a more proactive hand in monitoring their safety. For the Namibian TWG, active surveillance was the answer.

23 October 2023